Thus, the Sph-1 PD model share this characteristic phenotype with other animal models of the disease (e.g. the Pink1 mutant flies)25, and provides an excellent opportunity to evaluate the effect of potential therapeutic molecules on early stages of PD progression. This evidence concerns the gene PINK1 and Parkinson disease.